Trajectories of Cannabis use Beginning in Adolescence Associated with Symptoms of Posttraumatic stress Disorder in the Mid-Thirties
- 1 January 2018
- journal article
- research article
- Published by SAGE Publications in Substance Abuse
- Vol. 39 (1) , 39-45
Abstract
Background: Posttraumatic stress disorder (PTSD) symptoms are related to a number of adverse consequences such as substance use and general medical conditions. The present longitudinal study seeks to find the longitudinal patterns of cannabis use as precursors of PTSD symptoms. Such information will serve as a guide for intervention programs for PTSD. Methods: Growth mixture modeling was conducted to identify the cannabis use trajectory groups using a community sample of 674 participants (53% African Americans, 47% Hispanics of Puerto Rican decent; 60% females) from the Harlem Longitudinal Development Study. Logistic regression analyses were performed to examine the association between earlier trajectories of cannabis use (ages 14 to 36) and later symptoms of PTSD (at age 36) for the full model including the entire sample (N = 674) as well as the reduced model including only participants who had experienced a traumatic event (n = 205). Results: Five trajectory groups of cannabis use were obtained. The chronic use group (full model: adjusted odds ratio [AOR] = 4.68, P < .01; reduced model: AOR = 4.27, P < .05), the late quitting group (full model: AOR = 6.18, P < .01; reduced model: AOR = 6.67, P < .01), and the moderate use group (full model: AOR = 3.97, P < .01; reduced model: AOR = 3.32, P < .05) were all associated with an increased likelihood of having PTSD symptoms at age 36 compared with the no use group. Conclusions: The findings provide information that PTSD symptoms in the mid-30s can possibly be reduced by decreasing membership in the chronic cannabis use trajectory group, the late quitting trajectory group, and the moderate cannabis use trajectory group.Keywords
Funding Information
- National Cancer Institute (CA084063)
- National Institute on Drug Abuse (1K01 DA041609-01A1,DA05702)
This publication has 38 references indexed in Scilit:
- Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography studyMolecular Psychiatry, 2013
- The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD)Frontiers in Behavioral Neuroscience, 2013
- Joint trajectories of victimization and marijuana use and their health consequences among urban African American and Puerto Rican young menJournal of Behavioral Medicine, 2012
- Posttraumatic stress and marijuana use coping motives: The mediating role of distress toleranceJournal of Anxiety Disorders, 2011
- Substance use, childhood traumatic experience, and Posttraumatic Stress Disorder in an urban civilian populationDepression and Anxiety, 2010
- Race/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United StatesPsychological Medicine, 2010
- PTSD contributes to teen and young adult cannabis use disordersAddictive Behaviors, 2010
- Prevalence of Depression–PTSD Comorbidity: Implications for Clinical Practice Guidelines and Primary Care-based InterventionsJournal of General Internal Medicine, 2007
- Smoking, traumatic event exposure, and post-traumatic stress: A critical review of the empirical literatureClinical Psychology Review, 2007
- Marijuana Use From Adolescence to Young Adulthood: Multiple Developmental Trajectories and Their Associated Outcomes.Health Psychology, 2004